The Sarah Cannon Research Institute is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.
The Sarah Cannon Research Institute has participated in 46 clinical trials with 2 currently active.
Therapeutic areas: Head and Neck Cancer Squamous Cell Carcinoma, Non-small Cell Lung Cancer, Gastric Cancer.
Sponsors: ADC Therapeutics S.A., Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Sarah Cannon Research Institute has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Sarah Cannon Research Institute has 46 clinical trials on record, with 2 currently active. Their work covers Head and Neck Cancer Squamous Cell Carcinoma, Non-small Cell Lung Cancer, Gastric Cancer.
The Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.